BPC-157
Péptido sintético estudiado para reparación tisular y recuperación
Product Specifications
Description
All presented information is based on scientific publications which can be found at the end of product description below.
BPC-157 es un péptido sintético investigado para la reparación de tejidos, soporte intestinal, recuperación de tendones y ligamentos, y aplicaciones relacionadas con la cicatrización de heridas. Está listado como compuesto de investigación únicamente y no para uso humano o veterinario.
Research Use Only: The product is intended for scientific research and development purposes only. Chemical substances shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals. Intended only for in-vitro research, such as Receptor-ligand binding studies, Enzyme activity assays, Cell proliferation assays, Cell signaling assays, Epitope mapping, etc.
🇪🇺 EU & UK Shipped • Free over €300 • 2-5 Business Days
Frequently asked questions
- BPC-157 is a 15-amino-acid pentadecapeptide with sequence GEPPPGKPADDAGLV (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), molecular formula C₆₂H₉₈N₁₆O₂₂, and a molecular weight of approximately 1419.5 g/mol. Each batch ships with a Certificate of Analysis confirming sequence identity by mass spectrometry.
- Each batch is HPLC-MS verified at ≥99% purity. The COA includes the chromatogram, mass spectrometry trace, lot number, and synthesis date.
- Lyophilised BPC-157 is stable for 12-24 months at -20 °C in a sealed vial protected from light. Once reconstituted in sterile water or buffer, follow your laboratory's standard handling protocols — most workflows assume short-term stability at 2-8 °C.
- BPC-157 has been investigated in rodent models of tendon and ligament repair, gastrointestinal mucosal protection, anastomotic healing, skin wound closure, and neurovascular injury. All published evidence is preclinical — no large human trials have been conducted.
- No. BPC-157 is not approved by the FDA, EMA, or any other major regulatory body for human or veterinary use, and it is on the WADA Prohibited List (S0). It is supplied strictly for laboratory research only.
